Protea Biosciences, Inc. Expands Its Bioanalytical Services Capabilities

Published: Mar 13, 2012

ORLANDO, Fla., March 13, 2012 (GLOBE NEWSWIRE) -- Pittcon Conference -- Protea Biosciences Group, Inc., a leading developer of technologies and services for biomolecular analysis, announced today that the company is expanding its bioanalytical services business into a new, state-of-the-art 11,000 sq. ft. facility, providing innovative mass spectrometry services to the biopharma market. The facility is located in Morgantown, WV. The new space will advance the continued growth of the current mass spectrometry services business by providing additional instrumentation and increased analytical capabilities, including the use of the LAESI DP-1000 system for distribution profiling of biomolecules. The new facility is expected to be operational in the last week of April.

Back to news